R

ReShape Lifesciences
D

RSLS

1.14000
USD
-0.10
(-8.06%)
مغلق
حجم التداول
29,975
الربح لكل سهم
-17
العائد الربحي
-
P/E
0
حجم السوق
3,767,799
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ANY
    -0.05070
    (-7.13%)
    0.66000 USD
    B
    BNGO
    0.01500
    (0.28%)
    5.36500 USD
    I
    INUV
    -0.03460
    (-7.37%)
    0.43510 USD
    I
    IZEA
    -0.01800
    (-0.69%)
    2.57600 USD
    S
    SINT
    0.51000
    (10.34%)
    5.44000 USD
    V
    VXRT
    0.00670
    (0.95%)
    0.70980 USD
    المزيد
الأخبار
المقالات

العنوان: ReShape Lifesciences Inc

القطاع: Healthcare
الصناعة: Medical Devices
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus.